Duccio Medini | Chief Technology and Science Officer
Pitt BioForge

Duccio Medini is a scientist and pharmaceutical executive currently serving as Chief Science and Technology Officer at Pitt BioForge (Pittsburgh, PA) and as Strategic Data Science Director at Toscana Life Sciences Foundation (Siena, Italy)

He designed and led the Wellcome Leap $60M "R3: RNA Readiness and Response" program, co-funded by CEPI, developing standardized, multi-product, cell-free continuous RNA manufacturing, technologies that provide democratized access to diverse biologics and sustainable pandemic response, demonstrated by multiple INDs, and successfully transitioned the program to its second funding cycle, R3 Global.

In executive roles of growing responsibility at Chiron, Novartis and GSK corporations, he led hundreds of data scientists in Vaccines R&D and AI across Europe, US, and Asia, holding Research Board, Innovation Board, Clinical Quality Board and Data Governance Board responsibilities.

Working across biological discovery, clinical development and public health, he discovered the pangenome concept co-founding the pangenomics discipline, contributed to the successful registration of four novel vaccines, including the first universal vaccine against the serogroup B meningitis, led the Meningococcal Antigen Typing System (MATS) platform worldwide, developed transformative corporate data strategies, authored 70+ publications, books and patents in data science for health, population genomics and mathematical vaccinology.

Prof. Medini received his Ph.D. in Physics from the University of Perugia, Italy, with a residency at the Northeastern University in Boston, MA; is Habilitated Full Professor of Molecular Biology; has served in international PhD school committees at the Perugia and Turin Universities in Italy; is honorary member of the Cuban Immunology Society, Fellow of the ISI Foundation, Board member of the WHO mRNA Hub program and of the New Zealand National RNA program, Steering Committee member of the Global Pandemic Prevention & Biodefense Center at Connected DMV; an IMD, ADVAC and UC Berkley alumnus.